FDA Output
FDA Output, August 2026
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in August 2026. Updated August 5.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Medtech Capital Matters
MedTech Capital Matters July 2026
A summer without a slump? Our picks for the most intriguing recent private financings.
Business Strategies
The Innovation Flow: How Urology’s Leading Society Is Accelerating a New Wave of Innovation
Video Interviews
Precision Diagnostics Is Having a Moment: Canaccord’s Kyle Mikson Explains the Catalysts, Trends, and Competitive Landscape
Business Strategies
XVIVO Brings HOPE to Heart Transplant Patients
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
ICYMI
AI-Enabled Virtual ICUs
A digital twin ICU project at the University of Florida keeps humans between AI and the patient. Excerpted from our recent feature, The Nuts and Bolts of Artificial Intelligence in Medtech.